IRIS
SCHENONE, ANGELO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 38.097
AS - Asia 4.965
NA - Nord America 4.184
Continente sconosciuto - Info sul continente non disponibili 699
SA - Sud America 417
AF - Africa 94
OC - Oceania 7
Totale 48.463
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 37.348
US - Stati Uniti d'America 3.876
SG - Singapore 1.931
CN - Cina 1.221
VN - Vietnam 802
BD - Bangladesh 470
FR - Francia 313
BR - Brasile 238
HK - Hong Kong 167
CA - Canada 127
AR - Argentina 69
DE - Germania 69
JP - Giappone 68
FI - Finlandia 67
MX - Messico 63
NL - Olanda 51
IN - India 48
IQ - Iraq 42
GB - Regno Unito 40
ID - Indonesia 37
ES - Italia 34
CH - Svizzera 30
CO - Colombia 27
JM - Giamaica 27
EC - Ecuador 24
ZA - Sudafrica 22
PK - Pakistan 21
CR - Costa Rica 20
PH - Filippine 18
RU - Federazione Russa 18
TR - Turchia 18
VE - Venezuela 17
CL - Cile 15
IE - Irlanda 15
JO - Giordania 15
GT - Guatemala 14
PL - Polonia 14
TN - Tunisia 14
TH - Thailandia 13
KE - Kenya 11
PY - Paraguay 11
UA - Ucraina 11
HN - Honduras 10
MY - Malesia 10
TW - Taiwan 10
AT - Austria 9
SA - Arabia Saudita 9
BE - Belgio 8
NI - Nicaragua 8
NP - Nepal 8
PR - Porto Rico 8
SV - El Salvador 8
AL - Albania 7
DZ - Algeria 7
LT - Lituania 7
MA - Marocco 7
RO - Romania 7
AU - Australia 6
AZ - Azerbaigian 6
EG - Egitto 6
IL - Israele 6
TT - Trinidad e Tobago 6
UY - Uruguay 6
AE - Emirati Arabi Uniti 5
BO - Bolivia 5
DK - Danimarca 5
ET - Etiopia 5
LV - Lettonia 5
PT - Portogallo 5
SE - Svezia 5
DO - Repubblica Dominicana 4
GH - Ghana 4
HR - Croazia 4
KZ - Kazakistan 4
MD - Moldavia 4
UZ - Uzbekistan 4
BB - Barbados 3
BG - Bulgaria 3
GE - Georgia 3
GR - Grecia 3
HU - Ungheria 3
KG - Kirghizistan 3
KR - Corea 3
LB - Libano 3
MM - Myanmar 3
OM - Oman 3
PE - Perù 3
RS - Serbia 3
SC - Seychelles 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
SY - Repubblica araba siriana 3
AG - Antigua e Barbuda 2
AM - Armenia 2
BW - Botswana 2
BZ - Belize 2
CY - Cipro 2
IS - Islanda 2
MN - Mongolia 2
NG - Nigeria 2
Totale 47.738
Salva come PNG Salva come JPEG
Città #
Genova 20.049
Genoa 10.701
Rapallo 3.110
Vado Ligure 2.735
Singapore 947
San Jose 946
Ashburn 378
Lauterbourg 275
Ho Chi Minh City 240
Beijing 228
Hanoi 197
New York 165
Hong Kong 154
Santa Clara 114
Los Angeles 99
Bordighera 93
Council Bluffs 83
Rome 71
Tokyo 64
Milan 61
Helsinki 60
Buffalo 49
Frankfurt am Main 49
Chicago 45
Houston 41
Atlanta 37
Haiphong 37
Mexico City 36
Orem 36
Da Nang 33
Boardman 31
Phoenix 31
São Paulo 30
Dallas 28
Turin 27
Zurich 25
Tianjin 23
Biên Hòa 22
Montreal 21
Naples 21
Amsterdam 20
Bologna 20
Philadelphia 20
Baghdad 18
Brooklyn 18
Kingston 18
Toronto 18
Shanghai 16
Bắc Ninh 15
Hải Dương 15
Las Vegas 15
Louisville 15
Dublin 14
Johannesburg 14
San Francisco 14
Amman 13
Tampa 13
Warsaw 13
Florence 12
Madrid 12
San José 12
Washington 12
Can Tho 11
Guatemala City 11
Vienna 11
Calgary 10
Des Moines 10
Memphis 10
Nairobi 10
Padua 10
Kansas City 9
Orlando 9
Piscataway 9
Queens 9
Santiago 9
Vancouver 9
Ancona 8
Bari 8
Bergamo 8
Cardiff 8
City of London 8
Nuremberg 8
San Antonio 8
San Salvador 8
Thái Bình 8
Augusta 7
Changsha 7
Chennai 7
Chula Vista 7
Cincinnati 7
Columbus 7
Jacksonville 7
London 7
Managua 7
Miami 7
Milwaukee 7
Nashville 7
New Orleans 7
Newark 7
Paris 7
Totale 42.043
Salva come PNG Salva come JPEG
Nome #
Unclassified clinical presentations of chronic inflammatory demyelinating polyradiculoneuropathy 354
17p11.2 duplication is a common finding in sporadic cases of charcot-marie-tooth type 1 242
Dysimmune mononeuropathies: A diagnosis not to be missed 239
Experimental Charcot-Marie-Tooth type 1A: A cDNA microarrays analysis 224
Clinical epidemiology of ALS in Liguria, Italy. 219
Does parkin play a role in the peripheral nervous system? A family report 214
Autoimmune central diabetes insipidus in a patient with ureaplasma urealyticum infection and review on new triggers of immune response. 214
Acute axonal form of Guillain-Barre syndrome in a multiple sclerosis patient: chance association or linked disorders? 211
Sphingomyelin as a myelin biomarker in CSF of acquired demyelinating neuropathies 211
HSPB1 and HSPB8 in inherited neuropathies: study of an Italian cohort of dHMN and CMT2 patients 208
A novel compound heterozygous mutation ofC20orf54gene associated with Brown-Vialetto-Van Laere syndrome in an Italian family 207
Early abnormalities in sciatic nerve function and structure in a rat model of Charcot-Marie-Tooth type 1A disease. 206
A cross-sectional study investigating frequency and features of definitely diagnosed diabetic painful polyneuropathy 206
Tolerability and efficacy study of P2X7 inhibition in experimental Charcot-Marie-Tooth type 1A (CMT1A) neuropathy 205
A novel mutation of GDAP1 associated with Charcot-Marie-Tooth disease in three Italian families: evidence for a founder effect 202
Consistence and discrepancy of neuropathic pain screening tools DN4 and ID-Pain. 202
The diadenosine homodinucleotide P18 improves in vitro myelination in experimental Charcot-Marie-Tooth type 1A 201
Sural nerve biopsy and functional studies support the pathogenic role of a novel MPZ mutation. 200
An abnormal mRNA produced by a novel PMP22 splice site mutation associated with HNPP 200
Hand Rehabilitation Treatment for Charcot-Marie-Tooth Disease: An Open Label Pilot Study 199
A novel mutation in the N-terminal acting-binding domain of Filamin C protein causing a distal myofibrillar myopathy 197
Hereditary motor and sensory neuropathy with deafness, mental retardation and absence of large myelinated fibers. 196
Hereditary motor and sensory neuropathy with myelin outfolding: clinical, genetic and neuropathological study of three cases 196
Mycophenolate mofetil in dysimmune neuropathies: a preliminary study. 195
GDAP1 mutation in autosomal recessive Charcot-Marie-Tooth with pyramidal features. 193
Diagnostic Value of Sural Nerve Biopsy: Retrospective Analysis of Clinical Cases From 1981 to 2017 193
Charcot-Marie-Tooth (CMT) 1a duplication at 17p11.2 in Italian families. 192
GDAP1 mutations in Italian axonal Charcot-Marie-Tooth patients: Phenotypic features and clinical course 192
Evaluation of the psychometric properties of the EORTC chemotherapy-induced peripheral neuropathy questionnaire (QLQ-CIPN20) 192
Axonal damage and demyelination in long-term dorsal root ganglia cultures from a rat model of Charcot-Marie-Tooth type 1A disease 191
Ascorbic acid in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial. 190
AN IN VITRO MODEL OF MYELIN PROTEIN ZERO MUTATIONS IN SCHWANN CELLS 190
Both Schwann cell and axonal defects cause motor peripheral neuropathy in Ebf2-/- mice. 188
Different cellular and molecular mechanisms for early and late-onset myelin protein zero mutations 186
Alterations in the Arf6-regulated plasma membrane endosomal recycling pathway in cells overexpressing the tetraspan protein Gas3/PMP22 185
Deficiency of hyccin, a newly identified membrane protein, causes hypomyelination and congenital cataract 185
A novel prion protein gene-truncating mutation causing autonomic neuropathy and diarrhea 185
147th ENMC International Workshop: Guideline on processing and evaluation of sural nerve biopsies, 15-17 December 2006, Naarden, The Netherlands. 184
Direct immunofluorescence in sural nerve biopsies. 184
Guillain-Barré syndrome following chickenpox: A case series 184
A nationwide retrospective analysis on the effect of immune therapies in patients with chronic inflammatory demyelinating polyradiculoneuropathy 182
Alternative Splicing in the Human PMP22 Gene: Implications in CMT1A Neuropathy 182
Intense immunosuppression followed by autologous stem cell transplantation in severe multiple sclerosis. 182
Soluble Neuregulin1 is strongly up-regulated in the rat model of Charcot-Marie-Tooth 1A disease 181
Gain of glycosylation: a new pathomechanism of Myelin Protein Zero mutations 180
A case of secondary syphilis presenting as optic neuritis 180
Influence of comorbidities on the phenotype of patients affected by Charcot–Marie–Tooth neuropathy type 1A 180
Genetic Workup for Charcot–Marie–Tooth Neuropathy: A Retrospective Single-Site Experience Covering 15 Years 180
Underexpression of messenger RNA for peripheral myelin protein 22 in hereditary neuropathy with liability to pressure palsies 178
GFAP expression of human Schwann cells in tissue culture. 178
Reliability of clinical outcome measures in Charcot-Marie-Tooth disease. 177
"Limbic encephalitis with acute onset and Hu antibodies treated with rituximab: Paraneoplastic or non-paraneoplastic disorder?" 177
Autologous stem cell transplantation as rescue therapy in malignant forms of multiple sclerosis. 176
Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial. 176
Levodopa-induced neutropenia. 176
Monitoring effectiveness and safety of Tafamidis in transthyretin amyloidosis in Italy: a longitudinal multicenter study in a non-endemic area 176
Early electophysiological changes in transgenic rat model of charcot-marie-tooth. 175
An Italian family with Ala-47 transthyretin mutation associated with cardiomyopathy and polyneuropathy. 175
[Hereditary sensory motor neuropathy: degenerative disease or a disease with an immune-mediated pathogenesis?]. 175
Autosomal-dominant transthyretin (TTR)-related amyloidosis is not a frequent CMT2 neuropathy "in disguise" 175
Impaired expression of ciliary neurotrophic factor in Charcot-Marie-Tooth type 1A neuropathy 174
Mitichondrial dysfunction in experimental Charcot-marie-Tooth type 1° (CMTIA) neuropathy: a possible key factor for the axonal degeneration 173
Impairment of central motor conduction in diabetic patients. 172
Different movement disorders responsive to carbamazepine in patients with brainstem focal lesions 172
Testing overwork weakness in Charcot-Marie-tooth disease: Is it true or false? 172
Relapses after treatment with rituximab in a patient with multiple sclerosis and anti myelin-associated glycoprotein polyneuropathy. 171
Innovative quantitative testing of hand function in Charcot-Marie-Tooth neuropathy 171
Mutation update for myelin protein zero-related neuropathies and the increasing role of variants causing a late-onset phenotype 171
Use of cosH1 probe in hereditary neuropathy with liability to pressure palsies: a reliable genetic test for demonstration of identical size of 17p11.2 deletion in unrelated patients. 170
The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings. 170
Severe neuropathy after Diphtheria-Tetanus-Pertussis vaccination in a child carrying a novel frame-shift mutation in the small haet-shock protein 27 gene (HSPB1). 170
Bannwarth syndrome: report of two cases 169
Phenotypic characterization of hypomyelination and congenital cataract 169
Peripheral Nerve Society Guideline on processing and evaluation of nerve biopsies. 168
Responsiveness of gait analysis parameters in a cohort of 71 CMT subjects 168
Class II antigen expression on human cultured Schwann cells from patients with Charcot-Marie-Tooth disease. 167
High-dose Ig VENA is well tolerated and efficacious in patients with multifocal motor neuropathy 167
l-Acetyl-carnitine in Patients with Carpal Tunnel Syndrome: Effects on Nerve Protection, Hand Function and Pain 167
Dopamine-agonist responsive Parkinsonism in a patient with the SANDO syndrome caused by POLG mutation. 166
Progressive sensory-motor polyneuropathy with tomaculous changes is associated to 17p11.2 deletion. 166
Expression of common acute lymphoblastic leukemia antigen (CD 10) by myelinated fibers of the peripheral nervous system. 166
Impairment of PMP22 transgenic Schwann cells differentiation in culture: implications for Charcot-Marie-Tooth type 1A disease. 165
The D355V mutation decreases EGR2 binding to an element within the Cx32 promoter. 165
Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS) 165
Outcome measures in the clinical evaluation of ambulatory Charcot Marie Tooth 1A subjects 165
Rasch-Transformed Total Neuropathy Score clinical version (RT-TNSc©) in patients with chemotherapy-induced peripheral neuropathy 165
Natural history of CMT1A including QoL: a 2-year prospective study. 164
PMP22 transgenic dorsal root ganglia cultures show myelin abnormalities similar to those of human CMT1A. 164
Sonography of the median nerve in Charcot-Marie-Tooth disease 164
Psychological considerations in the assessment and treatment of pain in neurorehabilitation and psychological factors predictive of therapeutic response: Evidence and recommendations from the Italian consensus conference on pain in neurorehabilitation 164
The SPTLC1 p.S331 mutation bridges sensory neuropathy and motor neuron disease and has implications for treatment 163
Schwann cell GFAP expression increases in axonal neuropathies. 163
Genotype-Phenotype correlations of MPZ mutations 163
Charcot-Marie-Tooth and pain: correlations with neurophysiological, clinical, and disability findings. 163
Correlation among demyelination and axonal degeneration: a new trophic role for myelin sheath 163
Psychological treatments and psychotherapies in the neurorehabilitation of pain: Evidences and recommendations from the italian consensus conference on pain in neurorehabilitation 163
A multicenter retrospective study of charcot-marie-tooth disease type 4B (CMT4B) associated with mutations in myotubularin-related proteins (MTMRs) 162
Contribution of copy number variations in CMT1X: a retrospective study. 161
Expanding the spectrum of genes responsible for hereditary motor neuropathies. 160
Insulin treatment enhances expression of IGF-I in sural nerves of diabetic patients. 158
Totale 18.382
Salva come PNG Salva come JPEG
Categoria #
all - tutte 161.635
article - articoli 150.470
book - libri 0
conference - conferenze 10.371
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 794
Totale 323.270
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.635 121 259 308 425 131 207 202 826 188 331 134 503
2022/20233.735 370 338 37 380 612 628 28 247 622 28 389 56
2023/20242.410 129 263 93 328 171 417 214 162 114 68 128 323
2024/20257.139 306 481 246 482 889 680 654 1.214 342 306 701 838
2025/202613.537 1.617 415 738 917 1.781 1.043 1.932 717 851 1.384 1.256 886
2026/20271.155 1.155 0 0 0 0 0 0 0 0 0 0 0
Totale 48.463